Study Ties Essure CONTRACEPTIVE Implant to Greater Dependence on Reoperation: – TUESDAY, Oct. 13, 2015 – – New analysis raises worries about Essure, an implanted long-term contraceptive device that’s already the focus of controversy. Researchers found a 10-fold higher threat of needing a reoperation through the first calendar year for women who choose the Essure device in comparison to those who had minimally invasive surgery for sterilization FAQ . Essure works to avoid conception by blocking the fallopian tubes with metallic coils. This isn’t the first time the device, approved simply by the U first.S.
Although industry influence is indisputable, this explanation conflicts with the impression I got from Judy Faulkner, ceo of EHR maker Epic Systems, who advocates for government-created specifications. Whether or not other vendors are prepared to make their products interoperable, government frequently overrides industry’s financial interests to achieve a larger public good. I’m all for people with vision problems. However now I have to put my most talented staff upon this problem also before sorting out the fundamentals of transmitting info. Inside our iPhone-reverent age, the dismissal of EHR critics as Luddites is definitely supported by the recognition that technology we once couldn’t imagine we now can’t live without.